An updated clinical guideline from the American Society for Radiation Oncology (ASTRO) provides evidence-based recommendations on the use of hypofractionated radiation therapy for patients with localized prostate cancer. ...
2 hours ago
0
0
Adding the targeted radioactive drug 177Lu-PNT2002 to stereotactic body radiation therapy, or SBRT, may help keep recurrent prostate cancer under control longer than SBRT alone, according to new research led by investigators ...
Oct 13, 2026
0
98
A case report led by UCLA Health researchers highlights the importance of a multidisciplinary, evidence-based approach to treating prostate cancer that returns after surgery, particularly when the disease recurs multiple ...
Sep 30, 2026
0
6
Patients preparing for pancreatic cancer surgery maintained better physical function and experienced less fatigue with five treatments of stereotactic body radiation therapy (SBRT) than with 28 treatments of conventional ...
Sep 28, 2026
0
3
Five-treatment stereotactic body radiation therapy (SBRT) provided excellent long-term cancer control with fewer urinary and sexual side effects than surgery in the first randomized trial to directly compare the treatments ...
Sep 28, 2026
0
9
Results of the NRG Oncology NRG-GU005 clinical study comparing stereotactic body radiation therapy (SBRT) with moderately hypofractionated intensity-modulated radiation therapy (MH-IMRT) for patients with localized intermediate-risk ...
Aug 25, 2026
0
9
An updated clinical guideline from the American Society for Radiation Oncology (ASTRO) provides evidence-based recommendations on the use of radiation therapy to treat adult patients with pancreatic cancer.
Aug 13, 2026
0
5
Melanoma is the most aggressive form of skin cancer and can be difficult to treat in advanced stages. In a new doctoral thesis from Karolinska Institutet, Ellen Heurlin shows that radiotherapy combined with modern drug treatments ...
Jun 9, 2026
0
5
In recent decades, lung cancer treatment has been transformed—new surgeries, new radiation techniques, and dramatically improved outcomes. But according to new research from Yale, published in JAMA Network Open, one thing ...
Mar 4, 2026
0
10
Metastasis-directed therapy (MDT) significantly improved outcomes in patients with oligometastatic prostate cancer, according to a new study from researchers at The University of Texas MD Anderson Cancer Center published ...
Feb 3, 2026
0
8
